dc.contributor.author | Hamzaoglu, Kubra | |
dc.contributor.author | EREL, Cemal Tamer | |
dc.date.accessioned | 2021-03-02T16:31:39Z | |
dc.date.available | 2021-03-02T16:31:39Z | |
dc.identifier.citation | Hamzaoglu K., EREL C. T. , "Should estrogen be used in the co-treatment of COVID-19 patients? What is the rationale?", MATURITAS, cilt.140, ss.80, 2020 | |
dc.identifier.issn | 0378-5122 | |
dc.identifier.other | vv_1032021 | |
dc.identifier.other | av_877a6854-298e-4421-b451-2a4c931ea882 | |
dc.identifier.uri | http://hdl.handle.net/20.500.12627/3093 | |
dc.identifier.uri | https://doi.org/10.1016/j.maturitas.2020.06.015 | |
dc.language.iso | eng | |
dc.subject | Dahili Tıp Bilimleri | |
dc.subject | İç Hastalıkları | |
dc.subject | Geriatri | |
dc.subject | Cerrahi Tıp Bilimleri | |
dc.subject | Kadın Hastalıkları ve Doğum | |
dc.subject | Tıp | |
dc.subject | Sağlık Bilimleri | |
dc.subject | KADIN HASTALIKLARI & DOĞUM | |
dc.subject | Klinik Tıp (MED) | |
dc.subject | Klinik Tıp | |
dc.subject | GERİATRİK VE GERONTOLOJİ | |
dc.title | Should estrogen be used in the co-treatment of COVID-19 patients? What is the rationale? | |
dc.type | Makale | |
dc.relation.journal | MATURITAS | |
dc.contributor.department | İstanbul Üniversitesi-Cerrahpaşa , , | |
dc.identifier.volume | 140 | |
dc.identifier.startpage | 80 | |
dc.identifier.endpage | 80 | |
dc.contributor.firstauthorID | 2287394 | |